์„ฑ์žฅ ์ „๋žต ์„ค๊ณ„๋Š” ์šฐ๋ฆฌ์˜ DNA์— ์žˆ์Šต๋‹ˆ๋‹ค

์œ ๋Ÿฝ โ€‹โ€‹IV ๋‹จ๊ณ„ ์ž„์ƒ ์‹œํ—˜ ์‹œ์žฅ (์ถ”๊ฐ€ ์ •๋ณด)

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ :July 12, 2023 | ์ฒด์žฌ: | ์‹ ๊ณ  ID: 107732

 

์งˆ๋ฌธํ•˜๊ธฐ

man icon
Mail icon
Captcha refresh

OR

Quick Buy

๋น ๋ฅธ ๊ตฌ๋งค

์‹ ๋ขฐ ๋ฐ ์ธ์ฆ
ESOMAR
ISO 1 ISO 2
์‹œ์žฅ ์กฐ์‚ฌ ์š”๊ตฌ ์‚ฌํ•ญ์„ ์œ„ํ•ด ์šฐ๋ฆฌ๋ฅผ ์‹ ๋ขฐํ•˜๋Š” ๊ธฐ์—…๋“ค
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Europe Phase IV Clinical Trials Market (Additional Information)
  • ์ „์ง„
  • 2022
  • 2021-2024